HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression.

Abstract
Adoptive cell therapy with tumor-infiltrating lymphocytes (TILs) represents an effective treatment for patients with metastatic melanoma. However, most of the Ag targets recognized by effective melanoma-reactive TILs remain elusive. In this study, patient 2369 experienced a complete response, including regressions of bulky liver tumor masses, ongoing beyond 7 y following adoptive TIL transfer. The screening of a cDNA library generated from the autologous melanoma cell line resulted in the isolation of a mutated protein phosphatase 1, regulatory (inhibitor) subunit 3B (PPP1R3B) gene product. The mutated PPP1R3B peptide represents the immunodominant epitope recognized by tumor-reactive T cells in TIL 2369. Five years following adoptive transfer, peripheral blood T lymphocytes obtained from patient 2369 recognized the mutated PPP1R3B epitope. These results demonstrate that adoptive T cell therapy targeting a tumor-specific Ag can mediate long-term survival for a patient with metastatic melanoma. This study also provides an impetus to develop personalized immunotherapy targeting tumor-specific, mutated Ags.
AuthorsYong-Chen Lu, Xin Yao, Yong F Li, Mona El-Gamil, Mark E Dudley, James C Yang, Jorge R Almeida, Daniel C Douek, Yardena Samuels, Steven A Rosenberg, Paul F Robbins
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 190 Issue 12 Pg. 6034-42 (Jun 15 2013) ISSN: 1550-6606 [Electronic] United States
PMID23690473 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Immunodominant Epitopes
  • PPP1R3A protein, human
  • PPP1R3B protein, human
  • Phosphoprotein Phosphatases
  • Protein Phosphatase 1
Topics
  • Base Sequence
  • Clinical Trials as Topic
  • Flow Cytometry
  • Gene Knockdown Techniques
  • Gene Library
  • Humans
  • Immunodominant Epitopes (immunology)
  • Immunotherapy, Adoptive (methods)
  • Lymphocyte Activation (immunology)
  • Lymphocytes, Tumor-Infiltrating (immunology)
  • Male
  • Melanoma (genetics, immunology)
  • Molecular Sequence Data
  • Mutation
  • Phosphoprotein Phosphatases (genetics, immunology)
  • Protein Phosphatase 1 (genetics, immunology)
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: